Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).
(2016) In Annals of the Rheumatic Diseases 75(2). p.382-389- Abstract
- To define disease activity levels, minimal clinically important improvement (MCII) and patient-acceptable symptom state (PASS) with the primary Sjögren's syndrome (SS) disease activity indexes: European League Against Rheumatism (EULAR) SS disease activity index (ESSDAI) and EULAR SS patient-reported index (ESSPRI).
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/4909571
- author
- Seror, Raphaèle
; Bootsma, Hendrika
; Saraux, Alain
; Bowman, Simon J
; Theander, Elke
LU
; Brun, Johan G
; Baron, Gabriel
; Le Guern, Véronique
; Devauchelle-Pensec, Valérie
; Ramos-Casals, Manel
; Valim, Valeria
; Dörner, Thomas
; Tzioufas, Athanasios
; Gottenberg, Jacques-Eric
; Solans Laqué, Roser
; Mandl, Thomas
LU
; Hachulla, Eric
; Sivils, Kathy L
; Ng, Wan-Fai
; Fauchais, Anne-Laure
; Bombardieri, Stefano
; Priori, Roberta
; Bartoloni, Elena
; Goeb, Vincent
; Praprotnik, Sonja
; Sumida, Takayuki
; Nishiyama, Sumusu
; Caporali, Roberto
; Kruize, Aike A
; Vollenweider, Cristina
; Ravaud, Philippe
; Meiners, Petra
; Brito-Zerón, Pilar
; Vitali, Claudio
and Mariette, Xavier
(Less) - organization
- publishing date
- 2016
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Annals of the Rheumatic Diseases
- volume
- 75
- issue
- 2
- pages
- 382 - 389
- publisher
- BMJ Publishing Group
- external identifiers
-
- pmid:25480887
- wos:000368955700010
- scopus:84954398507
- pmid:25480887
- ISSN
- 1468-2060
- DOI
- 10.1136/annrheumdis-2014-206008
- language
- English
- LU publication?
- yes
- id
- 3bead590-ade6-4eea-84be-1e596da16668 (old id 4909571)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/25480887?dopt=Abstract
- date added to LUP
- 2016-04-01 10:16:27
- date last changed
- 2025-02-24 12:54:02
@article{3bead590-ade6-4eea-84be-1e596da16668,
abstract = {{To define disease activity levels, minimal clinically important improvement (MCII) and patient-acceptable symptom state (PASS) with the primary Sjögren's syndrome (SS) disease activity indexes: European League Against Rheumatism (EULAR) SS disease activity index (ESSDAI) and EULAR SS patient-reported index (ESSPRI).}},
author = {{Seror, Raphaèle and Bootsma, Hendrika and Saraux, Alain and Bowman, Simon J and Theander, Elke and Brun, Johan G and Baron, Gabriel and Le Guern, Véronique and Devauchelle-Pensec, Valérie and Ramos-Casals, Manel and Valim, Valeria and Dörner, Thomas and Tzioufas, Athanasios and Gottenberg, Jacques-Eric and Solans Laqué, Roser and Mandl, Thomas and Hachulla, Eric and Sivils, Kathy L and Ng, Wan-Fai and Fauchais, Anne-Laure and Bombardieri, Stefano and Priori, Roberta and Bartoloni, Elena and Goeb, Vincent and Praprotnik, Sonja and Sumida, Takayuki and Nishiyama, Sumusu and Caporali, Roberto and Kruize, Aike A and Vollenweider, Cristina and Ravaud, Philippe and Meiners, Petra and Brito-Zerón, Pilar and Vitali, Claudio and Mariette, Xavier}},
issn = {{1468-2060}},
language = {{eng}},
number = {{2}},
pages = {{382--389}},
publisher = {{BMJ Publishing Group}},
series = {{Annals of the Rheumatic Diseases}},
title = {{Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).}},
url = {{http://dx.doi.org/10.1136/annrheumdis-2014-206008}},
doi = {{10.1136/annrheumdis-2014-206008}},
volume = {{75}},
year = {{2016}},
}